vs

Side-by-side financial comparison of PAR TECHNOLOGY CORP (PAR) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $120.1M, roughly 1.2× PAR TECHNOLOGY CORP). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 14.4%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-12.5M). Over the past eight quarters, PAR TECHNOLOGY CORP's revenue compounded faster (30.9% CAGR vs 22.5%).

PAR Technology Corp is a global provider of point-of-sale systems, restaurant management software, and integrated tech solutions. Its core segments serve food service, hospitality, and government security markets, offering cloud tools to streamline operations, enhance customer experiences, and boost efficiency for enterprise and small-to-medium clients.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

PAR vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$120.1M
PAR
Growing faster (revenue YoY)
TOI
TOI
+27.2% gap
TOI
41.6%
14.4%
PAR
More free cash flow
TOI
TOI
$14.7M more FCF
TOI
$2.2M
$-12.5M
PAR
Faster 2-yr revenue CAGR
PAR
PAR
Annualised
PAR
30.9%
22.5%
TOI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PAR
PAR
TOI
TOI
Revenue
$120.1M
$142.0M
Net Profit
$-7.5M
Gross Margin
41.2%
Operating Margin
-15.0%
-4.9%
Net Margin
-5.3%
Revenue YoY
14.4%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.52
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAR
PAR
TOI
TOI
Q4 25
$120.1M
$142.0M
Q3 25
$119.2M
$136.6M
Q2 25
$112.4M
$119.8M
Q1 25
$103.9M
$104.4M
Q4 24
$105.0M
$100.3M
Q3 24
$96.8M
$99.9M
Q2 24
$78.2M
$98.6M
Q1 24
$70.1M
$94.7M
Net Profit
PAR
PAR
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-18.2M
$-16.5M
Q2 25
$-21.0M
$-17.0M
Q1 25
$-24.4M
$-19.6M
Q4 24
$-13.2M
Q3 24
$-19.8M
$-16.1M
Q2 24
$54.2M
$-15.5M
Q1 24
$-18.3M
$-19.9M
Gross Margin
PAR
PAR
TOI
TOI
Q4 25
41.2%
Q3 25
41.3%
Q2 25
45.4%
Q1 25
46.5%
Q4 24
42.9%
Q3 24
44.5%
Q2 24
41.0%
Q1 24
37.2%
Operating Margin
PAR
PAR
TOI
TOI
Q4 25
-15.0%
-4.9%
Q3 25
-14.8%
-5.9%
Q2 25
-15.4%
-9.4%
Q1 25
-15.2%
-9.5%
Q4 24
-15.6%
-11.9%
Q3 24
-15.7%
-13.9%
Q2 24
-26.5%
-16.6%
Q1 24
-38.2%
-19.0%
Net Margin
PAR
PAR
TOI
TOI
Q4 25
-5.3%
Q3 25
-15.3%
-12.1%
Q2 25
-18.7%
-14.2%
Q1 25
-23.4%
-18.8%
Q4 24
-13.1%
Q3 24
-20.5%
-16.1%
Q2 24
69.3%
-15.7%
Q1 24
-26.1%
-21.0%
EPS (diluted)
PAR
PAR
TOI
TOI
Q4 25
$-0.52
$-0.04
Q3 25
$-0.45
$-0.14
Q2 25
$-0.52
$-0.15
Q1 25
$-0.60
$-0.21
Q4 24
$-0.56
$-0.14
Q3 24
$-0.56
$-0.18
Q2 24
$1.60
$-0.17
Q1 24
$-0.62
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAR
PAR
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$80.1M
Total DebtLower is stronger
$394.0M
Stockholders' EquityBook value
$825.1M
$-15.7M
Total Assets
$1.4B
$164.7M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAR
PAR
TOI
TOI
Q4 25
$80.1M
Q3 25
$93.0M
Q2 25
$85.7M
Q1 25
$92.2M
Q4 24
$108.6M
Q3 24
$118.4M
Q2 24
$142.5M
$9.9M
Q1 24
$72.5M
$29.8M
Total Debt
PAR
PAR
TOI
TOI
Q4 25
$394.0M
Q3 25
$393.4M
Q2 25
$392.8M
Q1 25
$392.3M
Q4 24
$368.4M
Q3 24
$466.7M
Q2 24
$378.7M
Q1 24
$378.2M
Stockholders' Equity
PAR
PAR
TOI
TOI
Q4 25
$825.1M
$-15.7M
Q3 25
$838.0M
$-12.3M
Q2 25
$859.1M
$-9.0M
Q1 25
$852.0M
$5.1M
Q4 24
$871.7M
$3.6M
Q3 24
$692.7M
$15.5M
Q2 24
$588.3M
$29.2M
Q1 24
$526.4M
$41.3M
Total Assets
PAR
PAR
TOI
TOI
Q4 25
$1.4B
$164.7M
Q3 25
$1.4B
$163.6M
Q2 25
$1.4B
$159.8M
Q1 25
$1.4B
$164.0M
Q4 24
$1.4B
$172.7M
Q3 24
$1.3B
$179.2M
Q2 24
$1.1B
$179.6M
Q1 24
$1.0B
$204.5M
Debt / Equity
PAR
PAR
TOI
TOI
Q4 25
0.48×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.46×
Q4 24
0.42×
Q3 24
0.67×
Q2 24
0.64×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAR
PAR
TOI
TOI
Operating Cash FlowLast quarter
$-11.8M
$3.2M
Free Cash FlowOCF − Capex
$-12.5M
$2.2M
FCF MarginFCF / Revenue
-10.4%
1.5%
Capex IntensityCapex / Revenue
0.7%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-30.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAR
PAR
TOI
TOI
Q4 25
$-11.8M
$3.2M
Q3 25
$8.4M
$-12.6M
Q2 25
$-6.6M
$-10.2M
Q1 25
$-17.2M
$-5.0M
Q4 24
$3.4M
$4.2M
Q3 24
$8.8M
$819.0K
Q2 24
$-13.8M
$-15.7M
Q1 24
$-23.6M
$-15.9M
Free Cash Flow
PAR
PAR
TOI
TOI
Q4 25
$-12.5M
$2.2M
Q3 25
$7.0M
$-13.2M
Q2 25
$-7.4M
$-11.4M
Q1 25
$-17.6M
$-5.3M
Q4 24
$3.2M
$2.4M
Q3 24
$8.4M
$417.0K
Q2 24
$-14.2M
$-17.5M
Q1 24
$-23.6M
$-16.5M
FCF Margin
PAR
PAR
TOI
TOI
Q4 25
-10.4%
1.5%
Q3 25
5.9%
-9.7%
Q2 25
-6.6%
-9.5%
Q1 25
-16.9%
-5.1%
Q4 24
3.0%
2.4%
Q3 24
8.7%
0.4%
Q2 24
-18.2%
-17.7%
Q1 24
-33.7%
-17.4%
Capex Intensity
PAR
PAR
TOI
TOI
Q4 25
0.7%
0.7%
Q3 25
1.1%
0.4%
Q2 25
0.7%
1.0%
Q1 25
0.4%
0.3%
Q4 24
0.2%
1.8%
Q3 24
0.4%
0.4%
Q2 24
0.5%
1.9%
Q1 24
0.1%
0.6%
Cash Conversion
PAR
PAR
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAR
PAR

Subscription Service$76.1M63%
Hardware$27.8M23%
Professional Service$16.2M13%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons